| Entry |
|
|---|
| Name |
Methylephedrine (BAN) |
|---|
| Formula |
C11H17NO
|
|---|
| Exact mass |
179.131
|
|---|
| Mol weight |
179.2588
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
|
|---|
| Remark |
| Product (DG01229): | D02109<JP> |
|
|---|
| Efficacy |
Bronchodilator, Adrenergic receptor agonist |
|---|
| Comment |
Phenethylamine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Interaction |
|
|---|
| Brite |
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Methylephedrine
D08206 Methylephedrine (BAN)
Second-class OTC drugs
Inorganic and organic chemicals
Methylephedrine
D08206 Methylephedrine (BAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01229 Methylephedrine
D08206 Methylephedrine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D08206 Methylephedrine (BAN)
ADRA2
D08206 Methylephedrine (BAN)
ADRB
D08206 Methylephedrine (BAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01229 Methylephedrine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C8x C 22.6479 -18.3731
2 C8x C 22.6479 -19.7757
3 C8x C 23.8401 -20.4769
4 C8x C 25.0322 -19.7757
5 C8y C 25.0322 -18.3731
6 C8x C 23.8401 -17.6718
7 C1c C 26.2946 -17.6718
8 C1c C 27.4868 -18.3731
9 N1c N 28.6790 -17.6718
10 C1a C 29.9413 -18.3731
11 C1a C 27.4868 -19.7757
12 O1a O 26.2946 -16.2692
13 C1a C 28.6790 -16.2692
BOND 13
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 8 11 1 #Up
12 7 12 1 #Up
13 9 13 1
|
|---|
